Albert David Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Albert David Share Price

725.6030.75 (4.43%)

Closed
As On: 12 Jun, 2026, 03:50 PM IST
As On: 12 Jun, 2026, 03:57 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	690.40
High	729.70
Low	690.40
Prev Close	694.85
Volume	7,757
VWAP(₹)	720.10

Key Metrics

PE Ratio(x)	-277.05
EPS - TTM(₹)	-2.62
MCap(₹ Cr.)	414.11
MCap Rank	98
PB Ratio(x)	1.02
Div Yield(%)	0.69
Face Value(₹)	10.00
52W High(₹)	957.50
52W Low(₹)	579.90
MCap/Sales	1.00
Beta(1 Month)	0.81
BV/Share(₹)	686.04

Albert David share price insights

Dividend Announcement
Company announced a dividend of Rs 5.0 per share on May 12, 2026 with record date of Jul 30, 2026.
Quarterly Topline Performance
Company witnessed QoQ revenue decline of 40.36%, which is lowest in the last 3 years. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 30.72% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
Albert David Share Price Update
Albert David Ltd. share price moved up by 4.43% from its previous close of Rs 694.85. Albert David Ltd. stock last traded price is 725.60
Share Price Value
Today/Current/Last 725.60725.00
Previous Day 694.85696.75

Found Insights useful?

Albert David Share Price Returns

1 Day	4.43%
1 Month	-7.11%
3 Months	5.63%
1 Year	-15.69%
3 Years	18.31%
5 Years	46.81%

Albert David Share Recommendations

Recent Recos

Target₹570
OrganizationIndependent Analyst
BUY

View all Stock Recommendations

News & Analysis

View all Albert David Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	61.03	102.33	85.10	92.60	69.78
Total Income Growth (%)	-40.36	20.25	-8.10	32.71	-5.80
Total Expenses	85.83	81.53	86.93	83.61	81.46
Total Expenses Growth (%)	5.28	-6.22	3.97	2.64	-3.15
EBIT	-24.80	20.80	-1.83	8.99	-11.68
EBIT Growth (%)	-219.25	-	-120.36	-	-
Profit after Tax (PAT)	-21.43	15.30	-3.30	7.94	-10.33
PAT Growth (%)	-240.06	-	-141.60	-	-
EBIT Margin (%)	-40.65	20.33	-2.15	9.71	-16.73
Net Profit Margin (%)	-35.12	14.96	-3.88	8.57	-14.80
Basic EPS (₹)	-37.56	26.81	-5.79	13.91	-18.10

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	341.05	375.35	420.01	356.96	329.35
Total Revenue Growth (%)	-9.14	-10.63	17.66	8.38	24.46
Total Expenses	340.53	350.12	322.73	306.23	282.06
Total Expenses Growth (%)	-2.74	8.49	5.39	8.57	18.92
Profit after Tax (PAT)	-1.49	17.20	75.42	36.17	35.26
PAT Growth (%)	-108.69	-77.19	108.49	2.60	59.23
Operating Profit Margin (%)	0.94	7.41	26.92	14.98	15.25
Net Profit Margin (%)	-0.44	4.97	20.80	10.59	11.24
Basic EPS (₹)	-2.62	30.14	132.15	63.39	61.78

All figures in Rs Cr, unless mentioned otherwise

Insights

Quarterly Topline Performance
Company witnessed QoQ revenue decline of 40.36%, which is lowest in the last 3 years. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 30.72% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	519.13	511.42	497.99	423.39	402.84
Total Assets Growth (%)	1.51	2.70	17.62	5.10	18.00
Total Liabilities	127.60	118.93	115.01	111.82	123.37
Total Liabilities Growth (%)	7.29	3.41	2.85	-9.36	27.16
Total Equity	391.54	392.48	382.98	311.57	279.47
Total Equity Growth (%)	-0.24	2.48	22.92	11.49	14.36
Current Ratio (x)	3.24	3.40	3.75	3.07	2.33
Total Debt to Equity (x)	0.07	0.03	0.01	0.01	0.01
Contingent Liabilities	0.00	7.50	5.27	8.23	2.81

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	-7.66	-28.44	45.50	10.52	40.36
Net Cash used in Investing Activities	-4.40	23.30	-33.25	-5.00	-39.70
Net Cash flow from Financing Activities	11.92	0.11	-8.27	-6.36	-4.88
Net Cash Flow	-0.12	-5.02	3.99	-0.83	-4.13
Closing Cash & Cash Equivalent	0.30	0.42	5.44	1.45	-1.49
Closing Cash & Cash Equivalent Growth (%)	-28.32	-92.33	276.29	-197.04	-132.08
Total Debt/ CFO (x)	-3.72	-0.35	0.05	0.38	0.09

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	-0.38	4.38	19.69	11.61	12.61
Return on Capital Employed (%)	0.78	6.29	24.46	15.77	16.27
Return on Assets (%)	-0.28	3.36	15.14	8.54	8.75
Interest Coverage Ratio (x)	4.91	79.45	325.13	131.04	106.40
Asset Turnover Ratio (x)	0.65	0.69	0.79	0.83	0.84
Price to Earnings (x)	-227.27	26.95	8.14	8.08	8.61
Price to Book (x)	0.86	1.18	1.60	0.94	1.09
EV/EBITDA (x)	25.60	14.46	5.60	4.53	5.10
EBITDA Margin (%)	3.87	9.43	28.81	17.49	18.06

Found Financials useful?

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
No Data Available
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Albert David	-277.05	1.06	-0.38	0.78	-0.28	-1.49	0.94	-0.44	-2.62	3.24	0.07	-3.72
Venus Remedies	23.37	3.62	15.48	19.39	12.03	11.28	17.43	13.35	76.89	2.44	0.00	0.00
Kilitch Drug	21.91	2.39	10.78	13.15	6.59	19.85	18.77	12.52	8.91	1.83	0.32	3.70
Zim Laboratories	104.83	2.07	1.97	6.13	1.08	-1.59	5.71	1.55	1.19	1.45	0.42	2.48
SMS Lifesciences Ind	24.56	1.85	8.10	10.61	3.80	1.79	9.47	5.33	57.26	1.04	0.51	2.92
Add More

Annual Ratios (%)

Choose from Peers

Bafna Pharma
Medico Remedies
Medicamen Bio
Lyka Labs
Nectar Lifesc

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 35,51,958 62.24 % 0.00
Pledge 0 0.00 % 0.00
FII 33,249 0.58 % -0.02
DII 93,913 1.64 % 0.00
MF 800 0.01 % 0.00
Others 20,28,042 35.54 % 0.02
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 62.24 62.24 62.24 62.24
Pledge 0.00 0.00 0.00 0.00
FII 0.58 0.60 0.60 0.84
DII 1.64 1.64 1.64 1.64
Mutual Funds 0.01 0.01 0.01 0.01
Others 35.54 35.51 35.51 35.28

Mutual Funds Ownership

No Data Available

Albert David Top Searches

Corporate Actions

Recent
General Meeting
-
May 12, 2026
Final
50%
May 12, 2026
Board Meeting
Audited Results & Final Dividend
May 04, 2026

Announced on	Meeting on
May 04, 2026	May 12, 2026
Audited Results & Final Dividend
Feb 02, 2026	Feb 11, 2026
Quarterly Results
Nov 06, 2025	Nov 12, 2025
Quarterly Results
Jul 25, 2025	Aug 02, 2025
Quarterly Results
May 06, 2025	May 13, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
May 12, 2026 Jul 30, 2026 50%
May 13, 2025 Jul 25, 2025 50%
May 13, 2024 Aug 02, 2024 115%
May 19, 2023 Aug 03, 2023 90%
May 11, 2022 Aug 01, 2022 90%
Bonus
No Data Available
Splits
No Data Available
Rights
Announced on Ex-Date
Mar 12, 1996 Feb 05, 1996
Rights ratio: 2 share for every 3 held at a price of Rs 20.0
Sep 30, 1993 Mar 26, 1993
Rights ratio: 1 share for every 2 held at a price of Rs 20.0
AGM/EGM Meetings
Announced on Meeting on
May 12, 2026 Aug 06, 2026
-
Sep 08, 2025 Oct 09, 2025
-
Aug 13, 2025 Sep 18, 2025
-
Jul 04, 2025 Aug 02, 2025
-
Nov 26, 2024 Dec 28, 2024
-

About Albert David

Albert David Ltd., incorporated in the year 1938, is a Small Cap company (having a market cap of Rs 414.11 Crore) operating in Pharmaceuticals sector.

Albert David Ltd. key Products/Revenue Segments include Pharmaceuticals, Scrap and Export Incentives for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Standalone Total Income of Rs 61.02 Crore, down 40.36 % from last quarter Total Income of Rs 102.33 Crore and down 12.55 % from last year same quarter Total Income of Rs 69.78 Crore. Company has reported net profit after tax of Rs -21.43 Crore in latest quarter.

The company’s top management includes Mr.Arun Kumar Kothari, Mr.Umesh Manohar Kunte, Mr.Anand Vardhan Kothari, Mrs.Prabhawati Devi Kothari, Mr.Anurag Singhi, Dr.Monjori Mitra, Mr.Naresh Pachisia, Mr.Shourya Sengupta, Mr.R Bhattacharya, Mr.Lalit Lohia. Company has L B Jha & Co. as its auditors. As on 31-03-2026, the company has a total of .57 Crore shares outstanding.

Albert David Share Price Today is Rs. 725.60. On previous day, the Albert David Share Price (NSE) closed at Rs. 694.85, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 62.24% of the stake in Albert David shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Albert David stocks was 0.58% as compared to 0.6% in Dec 2025 with decrease of 0.02%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 1.64% as compared to 1.64% in Dec 2025 with decrease of 0.0%. Out of the total DII holdings in Albert David shares 0.01% was held by mutual funds. The rest including public held is 35.54%. Albert David stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Albert David Dividend: Ever since 1938, Albert David dividends has been paid out around 29 times. As on 12 Jun, 2026, 03:50 PM IST, The overall dividend yield for Albert David stands at 0.69%. The last dividend paid was on July 30, 2026 (Rs. 5.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. -2.62.

Albert David Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 61.02 Cr. of sales and 40.36% of quarterly net loss, there have been multiple ups and downs in the Albert David stock prices in the past few weeks. For example, Albert David stock price on 5th of June 2026 was around Rs. 710.75. Albert David share price now stands at an average of Rs. 725.60. Judging by last week's performance, stock is in down trend.

Albert David has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Albert David share.

Historical Prices and Performance:
Albert David, incorporated in 1938 is a Small Cap company (with a market cap of Rs. 414.11) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Albert David stock was -0.38%, 4.38%, 19.69%, 11.61% and 12.61% respectively.
The Albert David share gave a 3 year return of 18.31% as compared to Nifty 50 which gave a return of 26.99%.
Albert David announced 50.0% final dividend on July 30, 2026.

Key Metrics:
PE Ratio of Albert David is -277.05
Prices/Sales Ratio of Albert David is 1.0
Price/Book Ratio of Albert David is 1.06

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Albert David, major competitors and peers include Venus Remedies, Kilitch Drug, Zim Laboratories and SMS Lifesciences Ind. As of Dec 2025, the dividend yield of Albert David stands at 0.69% while Venus Remedies, Kilitch Drug, Zim Laboratories and SMS Lifesciences Ind stand at 0.56%, 0.0%, 0.0% and 0.11% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at -277.05 and 1.06 respectively.

Leadership of Albert David :
Lalit Lohia is Co. Secretary & Compl. Officer
R Bhattacharya is Chief Financial Officer
A J Chattopadhyay is Corporate Head
C B Thakur is Head - Operations
S Bhattacharya is Head
Kuntal Ganguly is Head - Research & Development
Saikath Banerjee is Head
Arun Kumar Kothari is Exe.Chairman & W T D
Umesh Manohar Kunte is Managing Director & CEO
Prabhawati Devi Kothari is Non Executive Director
Anand Vardhan Kothari is Non Executive Director
Anurag Singhi is Ind. Non-Executive Director
Shourya Sengupta is Ind. Non-Executive Director
Monjori Mitra is Ind. Non-Executive Director
Naresh Pachisia is Ind. Non-Executive Director

Show More

Industry

Pharma - Indian

Key Indices Listed On

-

Address

D - Block, 3rd Floor,Gillander House,8 Netaji Subhas Road,Kolkata, West Bengal - 700001

Contact

albertdavid@adlindia.in

http://www.albertdavidindia.com

Executive Leadership

AK

Arun Kumar Kothari

Exe.Chairman & W T D

UM

Umesh Manohar Kunte

Managing Director & CEO

AV

Anand Vardhan Kothari

Non Executive Director

PD

Prabhawati Devi Kothari

Non Executive Director

Show More

Auditors

L B Jha & Co.

Basu Chanchani & Deb

FAQs about Albert David share

1. What's Albert David share price today and what are Albert David share returns ?
As on 12 Jun, 2026, 03:50 PM IST Albert David share price is up by 4.43% basis the previous closing price of Rs 700.4. Albert David share price is Rs 725.60. Return Performance of Albert David Shares:
- 1 Week: Albert David share price moved up by 2.09%
2. What is 52 week high/low of Albert David share price?
In last 52 weeks Albert David share had a high price of Rs 957.50 and low price of Rs 579.90
3. What's the market capitalization of Albert David?
Albert David share has a market capitalization of Rs 414.11 Cr. Within Pharmaceuticals sector, it's market cap rank is 98.
4. What is the PE & PB ratio of Albert David?
The PE ratio of Albert David stands at -265.31, while the PB ratio is 1.01.
5. What are the returns for Albert David share?
Return Performance of Albert David Shares:
- 1 Week: Albert David share price moved up by 2.09%

Top Gainers

As on 04:06 PM | 12 Jun 2026

84.57

14.09 (20.00%)

Authum Investment

530.15

70.20 (15.27%)

Tata Teleservices

46.44

4.29 (10.18%)

152.45

13.87 (10.01%)

Netweb Technologies

4,587.40

396.00 (9.45%)

Top Losers

As on 03:58 PM | 12 Jun 2026

1,375.70

-46.80 (-3.29%)

417.80

-11.56 (-2.70%)

246.20

-6.41 (-2.54%)

1,429.20

-35.90 (-2.46%)

OneSource Specialty

1,612.50

-38.91 (-2.36%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.